
The Attractiveness of Investing In Catalyst Pharmaceuticals Inc (CPRX) is Growing
Catalyst Pharmaceuticals Inc’s recently made public that its Chief Compliance/Legal Officer Elsbernd Brian unloaded Company’s shares for reported $0.61 million
Catalyst Pharmaceuticals Inc’s recently made public that its Chief Compliance/Legal Officer Elsbernd Brian unloaded Company’s shares for reported $0.61 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Catalyst Pharmaceuticals Inc revealed its Chief Compliance/Legal Officer Elsbernd Brian unloaded Company’s shares for reported $0.61 million
Catalyst Pharmaceuticals Inc’s recently made public that its Officer Elsbernd Brian acquired Company’s shares for reported $0.61 million on Sep
In a filing, Catalyst Pharmaceuticals Inc revealed its Director Tierney David S unloaded Company’s shares for reported $0.53 million on
Catalyst Pharmaceuticals Inc’s filing revealed that its Officer Miller Steve acquired Company’s shares for reported $2.33 million on Aug 26
Catalyst Pharmaceuticals Inc’s filing revealed that its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on Jun
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Catalyst Pharmaceuticals Inc’s filing revealed that its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Catalyst Pharmaceuticals